Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!

The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.

Importance of New Treatment Option

"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.

Symbravo Trial Results, How Was It Approved

The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.

While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.

And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.

When it comes to living with a common cold, the infection is not as simple as it sounds. There are headaches; you may feel irritable and may even sometimes struggle to sleep properly. A blocked or runny nose may even put you in awkward situations in a social setting; however, a new study says that catching a common respiratory virus could stop breast cancer cells from taking hold of your lungs. Researchers at the Francis Crick Institute in London and Imperial College London have discovered that RSV can benefit cancer patients to a great extent. Find out how.

How does RSV lower cancer risk?

The study, published in the PNAS journal, found that scientists who conducted tests on mice found that those who fought off RSV infection developed relatively fewer tumours in the lungs, the most common spot for breast cancer cells to spread. When breast cancer spreads to other body parts, it is known as secondary breast cancer. Scientists say that RSV infections have this effect when lung cells detect RSV-like viruses. They then produce immune cells to stop the virus from taking over. This makes it more difficult for cancer cells to form new tumours by taking control in the lungs.

For the study, cancer biologists introduced breast cancer cells to mice that had recently experienced an RSV infection. They developed fewer tumours (not smaller) in the lungs compared to mice that were not living with RSV infection. The infection also increases levels of Galectin-9, a protein that is responsible for enhancing the immune response to the virus and also for stopping cancer cells from taking over.

What do previous studies indicate?

Previous research shows that 60 per cent of stage four breast cancer patients developed tumours in their lungs. At present, the five-year survival rate stands at 30 per cent. Researchers also claim that the findings could pave the way for new treatments that may prevent tumours from spreading. However, it does not mean that RSV infections will be used for cancer treatment. Researchers noted that they can find ways to make the lungs more resistant to the successful seeding of cancer cells that have become metastatic. Experts say that a drug could be developed to replicate the effects observed in mice. Studies in humans can also help confirm whether the effect can be replicated.

Is RSV common?

RSV is common, but it can be fatal, especially in younger children. The virus results in thousands of hospitalisations every year and may lead to serious complications such as lung infections and pneumonia. The virus is a leading cause of death among babies in the UK, especially during winter. It is also expected to result in the deaths of 8,000 adults during the same period. The infection can put strain on a patient’s heart, causing organs to fail.

World Asthma Day is observed on May 5 every year, an event that is focused on spreading awareness about the causes, symptoms, and management of asthma. And for people living in India, this is a bigger cause of concern because the country is home to the world's hottest and most polluted cities. This year, on the occasion of World Asthma Day, experts shed light on the impact of severe heatwaves on asthma patients. Dr. Sandeep Kadian, Senior Consultant Pulmonologist and Intensivist, AIMS Hospital, Dombivli, in an interview with Health and Me, spoke about the impact of asthma on patients during a severe heatwave.

How does a heatwave affect asthma patients?

Summer heat, dust, and pollution can trigger asthma symptoms like cough and breathlessness. Hence, it is the need of the hour to take extra care during the warmer months. Here, the expert also highlights the vital tips to stay healthy. Cough and breathlessness are frequently experienced by asthma patients, and a heatwave can make these symptoms far more severe.

Dr Kadian explains that asthma is also a common occurrence in summer. While many people associate it with winter, summer can also be a challenging time for those living with asthma. So, the rising temperatures, increased air pollution, dust, pollen, and humidity can irritate the airways and trigger symptoms. People may experience coughing, wheezing, shortness of breath, and a feeling of tightness in the chest. During summer, hot air can cause the airways to become dry and sensitive.

At the same time, outdoor allergens like pollen and dust are more common. Air conditioners, if not cleaned regularly, can circulate dust and mold, further worsening symptoms. For children and adults alike, understanding these triggers and taking simple precautions can help prevent flare-ups and keep breathing under control. Even dehydration is another factor that can worsen asthma. When the body lacks fluids, the airways may become more irritated. Sudden temperature changes, like moving from extreme heat outside to very cold indoor air, can also trigger breathing problems.

Tips to manage asthma in summer

Dr Kadian shared some simple tips to help asthma patients deal with the symptoms amid a heatwave. Make sure to stay hydrated by drinking enough water; avoid extreme heat and high-pollution areas; wear a mask; keep the house clean, dust- and mold-free, and well-ventilated. Service air conditioners from time to time and prevent dust and mold buildup. Carry prescribed inhalers and use them as advised by the doctor. It is also necessary to take a bath and change clothes after coming from outdoors. Also, it is essential to take the flu and pneumococcal vaccines as advised by the doctor and stay healthy.

Asthma can be managed with awareness and simple daily care. Staying cautious and prepared is the key to breathing easy even in the heat. This summer, prioritise your respiratory health.

There have been six suspected cases of hantavirus — a rare but potentially deadly virus transmitted primarily by rodents — of which three have died, said the World Health Organization (WHO).

Also Read: WHO Says Suspected Hantavirus Killed 3 on Cruise Ship: Symptoms, Risks, and Prevention

The suspected hantavirus outbreak occurred on the MV Hondius cruise ship, Oceanwide Expeditions, in the Atlantic Ocean. It was travelling to the Canary Islands via Cape Verde from Argentina. The three people dead include a Dutch husband and wife, as well as a German national, according to the operator of the ship.

Speaking to the media, Maria Van Kerkhove, Director (a.i) Epidemic and Pandemic Preparedness and Prevention, WHO, said that the WHO is working with countries involved in the response to the hantavirus cases onboard a ship off Cabo Verde, as well as the ship's operators, and carrying out risk assessments to guide next steps.

“As of the fourth of May, there have been six suspected cases reported. Three cases have unfortunately died. One patient is currently ill in the ICU in South Africa, while two patients remain on board and will be evacuated for medical treatment. About a hundred and fifty people, including passengers and crew, are on the ship,” Van Kerkhove said.

The patient in the ICU is a 69-year-old UK national.

“The patient is still in critical condition in isolation but receiving medical attention,” according to a statement by South Africa’s Department of Health (DoH).

The WHO noted that it is working with countries to evacuate the two sick people on board to the Netherlands for medical care.

“At present, there are no other symptomatic people on the ship, but this is being carefully monitored,” Van Kerkhove said.

Adding that laboratory tests are also ongoing, she stated that “based on current information and what we know about the virus from previous outbreaks, the overall risk to the public is low.”

Also Read: Hantavirus Kills 3 on Cruise Ship: Symptoms, Risks, and Prevention

Hantavirus: How did the outbreak begin?

Some of the passengers onboard the Oceanwide Expeditions, travelling to the Canary Islands via Cape Verde from Argentina, with some 150 passengers, began experiencing serious health complications while the ship was travelling past South African shores. Initially, it was considered a severe acute respiratory infection; later, three people died.

“[The] first patient was a 70-year-old male passenger who suddenly became ill on the ship en route from Ushuaia to St Helena Island. Unfortunately, he passed away on arrival at St Helena Island. His mortal remains are in St Helena, awaiting repatriation to the Netherlands,”," South Africa’s DoH said.

Hantavirus Symptoms

The initial symptoms included:

• fever,
• headache,
• abdominal pain,
• diarrhea.

Hantavirus Alert: 890 US Cases

Meanwhile, the Centers for Disease Control and Prevention (CDC) noted that by the end of 2023, 890 cases of hantavirus disease were reported in the United States since surveillance began in 1993.

Hantavirus pulmonary syndrome (HPS) became a nationally notifiable disease in 1995 in the US.

Read More: CDC Flags Surge in US Tuberculosis Outbreaks, Cases Double Since 2017

What Is Hantavirus?

Globally, an estimated 100,000 to 200,000 hantavirus infections occur each year. The majority of these cases are in Asia, particularly China. Most are sporadic or occur in small clusters, linked to contact with infected rodents.

“Hantaviruses are a group of viruses carried by rodents that can cause severe disease in humans. Infection with hantaviruses is found in many parts of the world. Thousands of infections are estimated to occur each year," Van Kerkhove said.

Infection in people can result in severe illness and often death, although the diseases vary by type of virus and geographical location. In the Americas, infection has been known to lead to hantavirus cardiopulmonary syndrome (HCPS), a rapidly progressive condition affecting the lungs and heart, while in Europe and Asia, hantaviruses have been known to cause hemorrhagic fever with renal syndrome (HFRS), which primarily affects the kidneys and blood vessels.

Notably, the WHO has not specified the type of hantavirus or syndrome in the cruise incident, but did mention respiratory risks.

The hantavirus is primarily spread by rodents through

• exposure to their urine,
• droppings,
• saliva,
• less commonly through a scratch or bite.

According to the CDC, symptoms can appear one to eight weeks after exposure, initially presenting fatigue, fever, and muscle aches. As the disease progresses, it can cause coughing, shortness of breath, and chest tightness as fluid accumulates in the lungs.

The CDC reports that about one-third of individuals who develop respiratory symptoms from the disease may not survive.

How to Protect Yourself: 7 Ways to Reduce Hantavirus Risk

You can reduce your risk by eliminating and minimizing your contact with rodents in your home, workplace, or campsite.

Other effective measures include:

• keeping homes and workplaces clean
• sealing openings that allow rodents to enter buildings
• storing food securely
• using safe cleaning practices in areas contaminated by rodents
• avoiding dry sweeping or vacuuming rodent droppings
• dampening of contaminated areas before cleaning
• strengthening hand hygiene practices.